SER Serina Therapeutics
- 11.600
- -1.200-9.38%
- 11.510
- -0.090-0.78%
Serina Therapeutics News
Serina Therapeutics(SER.US) Director Buys US$60,591 in Common Stock
$Serina Therapeutics(SER.US)$ Director Bailey Gregory purchased 6,378 shares of common stock on May 29, 30, 2024 at an average price of $9.5 for a total value of $60,591.Source: Announcement What is s
Serina Therapeutics(SER.US) Director Buys US$85,680.5 in Common Stock
$Serina Therapeutics(SER.US)$ Director Bailey Gregory purchased 9,019 shares of common stock on May 28, 2024 at an average price of $9.5 for a total value of $85,680.5.Source: Announcement What is sta
Serina Therapeutics(SER.US) Director Buys US$31,226.5 in Common Stock
$Serina Therapeutics(SER.US)$ Director Bailey Gregory purchased 3,287 shares of common stock on May 21, 23, 2024 at an average price of $9.5 for a total value of $31,226.5.Source: Announcement What is
Serina Therapeutics(SER.US) Director Buys US$120.83K in Common Stock
$Serina Therapeutics(SER.US)$ Director MINTZ STEVEN purchased 12,380 shares of common stock on May 17, 20, 21, 2024 at an average price of $9.76 for a total value of $120.83K.Source: Announcement What
Serina Therapeutics(SER.US) Director Buys US$13,509 in Common Stock
$Serina Therapeutics(SER.US)$ Director Bailey Gregory purchased 1,422 shares of common stock on May 21, 2024 at an average price of $9.5 for a total value of $13,509.Source: Announcement What is state
Serina Therapeutics(SER.US) Director Buys US$900 in Common Stock
$Serina Therapeutics(SER.US)$ Director Bailey Gregory purchased 100 shares of common stock on May 20, 2024 at an average price of $9 for a total value of $900.Source: Announcement What is statement of
SCPX, XTIA and CRVO Among Mid-day Movers
Express News | Serina Therapeutics And Enable Injection Announced A Partnership To Develop And Commercialize SER-252 (POZ-apomorphine) In Combination With Enfuse For The Treatment Of Parkinson's Disease
Express News | Serina Therapeutics Inc: Enable Will Also Be Entitled to Product Sales and Single Digit Royalties.
Express News | Serina Therapeutics Inc: Will Obtain a Worldwide, Exclusive License to Enfuse Platform for an Upfront and Future Milestone Payments
Express News | Serina Therapeutics Inc - Plans to Advance Ser-252 to Clinical Testing in 2025
Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination With EnFuse for Advanced Parkinson's Disease
CINCINNATI and HUNTSVILLE, Alabama, May 15, 2024 (GLOBE NEWSWIRE) -- Enable Injections, Inc. ("Enable"), a healthcare innovation company developing and manufacturing the enFuse wearable drug delivery platform and
Express News | Serina Therapeutics Q1 2024 R&D Expenses $1.1M Vs $400K Prior
Express News | Serina Therapeutics Inc: Substantial Doubt Regarding Ability of Company to Continue as a Going Concern
Express News | Serina Therapeutics-Believes Cash, Cash Equivalents on May 9 Not Sufficient to Satisfy Expected Operating, Other Funding Requirements for 12 Months
10-Q: Quarterly report
Earnings Flash (SER) SERINA THERAPEUTICS Reports Q1 Revenue $5,000
04:14 PM EDT, 05/14/2024 (MT Newswires) -- Earnings Flash (SER) SERINA THERAPEUTICS Reports Q1 Revenue $5,000
Express News | Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
Serina Therapeutics Files Registration Statement for Potential Offering of Common Stock, Warrants
Serina Therapeutics (SER) on Friday filed a registration statement for the potential offering of up to about 3 million common shares issuable upon warrant exercises, and up to about 1.5 million warran
Serina Therapeutics Files to Sell 1.5M Shares of Common Stock
Analysis
Price Target
No Data
